Form 4: Mirum Pharmaceuticals CFO Sells Shares
Insider Transaction (Form 4)
Eric Bjerkholt, CHIEF FINANCIAL OFFICER of Mirum Pharmaceuticals, Inc., sold 9,943 shares of common stock on September 11, 2026 for $98.37 per share.
Summary
- Option exercise/conversion: acquired 18,333 Common Stock on September 11, 2026; holds 54,688 after (Direct).
- Open-market sale: disposed of 9,943 Common Stock at $98.37 ($978,093) on September 14, 2026; holds 44,745 after (Direct).
- Option exercise/conversion: disposed of 18,333 Restricted Stock Units on September 11, 2026 (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $978,093 of stock on the open market.
Insider Transactions
Eric Bjerkholt — Officer (CHIEF FINANCIAL OFFICER)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-11 | Option exercise/conversion | Common Stock | 18,333 | — | — | 54,688 |
| 2026-09-14 | Open-market sale | Common Stock | 9,943 | $98 | $978.1K | 44,745 |
| 2026-09-11 | Option exercise/conversion | Restricted Stock Units | 18,333 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-11 | Option exercise/conversion (18,333 shares) |
| 2026-09-14 | Open-market sale (9,943 shares) |
| 2026-09-11 | Option exercise/conversion (18,333 shares) |
Keywords
insider transaction, Form 4, MIRM, Mirum Pharmaceuticals, Inc., bearish, Eric Bjerkholt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.